CIDP - Chronic Inflammatory Demyelinating Polyneuropathy: Clinical Trials

1 trial for CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow CIDP - Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of CIDP - Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Immunoglobulin - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 4RecruitingUniversity of Aarhus602020-06-042024-05-17

Narrower conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Chronic Disease (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)  ·  Polyradiculoneuropathy (1)

Interventions

Immunoglobulins (1)

Sponsors

University of Aarhus (1)

Countries

Denmark (1)

Top investigators

Henning Andersen, MD,DMSc,PhD (1)

Results publications

PMID 42578463

NIH funding

2018 (1)